Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Uncategorized
Page 3
Uncategorized
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a...
atai Life Sciences Announces R&D Day Agenda
atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial...
atai Life Sciences Announces Positive Initial Results for Phase 1 Trial...
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial...
atai Life Sciences to Participate in October Investor Events & Host...
atai Life Sciences Announces Initiation of Phase 1 Trial for its...
atai Life Sciences to Participate in September Investor Events
atai Life Sciences Reports First Quarter 2022 Financial Results and Business...
atai Life Sciences to Announce First-Quarter 2022 Financial Results
1
2
3
4
...
12
Page 3 of 12